FMS · NYSE, OTC · CIK 0001333141

Fresenius Medical Care AG

Fresenius Medical Care AG’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 7, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $19.6B and net income of $978.4M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$19.6B
Net income, FY2025
$978.4M
Form 4 filings on record, past 12 months
0

Company overview

Legal name (as filed)
Fresenius Medical Care AG
Tickers
FMS, FMCQF
SEC Central Index Key (CIK)
0001333141
Business address
BAD HOMBURG, Germany
State or country of incorporation
—
Fiscal year ends
—
SEC filer category
Large accelerated filer
Position in SEC ticker list
#818 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Fresenius Medical Care AG’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$17.6BFY2021$19.4BFY2022$19.5BFY2023$19.3BFY2024$19.6BFY2025
Net income
$969.3MFY2021$673.4MFY2022$499.0MFY2023$537.9MFY2024$978.4MFY2025
FMS annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$17.6B$19.4B$19.5B$19.3B$19.6B
Net income$969.3M$673.4M$499.0M$537.9M$978.4M
Diluted EPS$3.31$2.30$1.70$1.83$3.36
Total assets—————
Cash and equivalents$925.1M$911.0M$1.1B$837.3M$929.7M

XBRL tags used: revenue = Revenue; netIncome = ProfitLossAttributableToOwnersOfParent; eps = DilutedEarningsLossPerShare; cash = Cash. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

FMS latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 24, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 7, 20266-KReport of a foreign private issuer· period Oct 7, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Fresenius Medical Care AG, by form type:

6-K ×29SCHEDULE 13D/A ×311-K ×2SD ×23 ×1SCHEDULE 13G ×1IRANNOTICE ×120-F ×1
FMS recent filings
FiledFormWhat it isOriginal
Oct 7, 20266-KReport of a foreign private issuer· period Oct 7, 2026Document · Index
Sep 25, 20266-KReport of a foreign private issuer· period Sep 25, 2026Document · Index
Aug 27, 20266-KReport of a foreign private issuer· period Aug 27, 2026Document · Index
Aug 24, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Aug 4, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Aug 3, 20266-KReport of a foreign private issuer· period Aug 3, 2026Document · Index
Aug 3, 20266-KReport of a foreign private issuer· period Aug 3, 2026Document · Index
Aug 3, 20266-KReport of a foreign private issuer· period Aug 3, 2026Document · Index
Jul 29, 20266-KReport of a foreign private issuer· period Jul 29, 2026Document · Index
Jul 28, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jun 29, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
May 28, 20266-KReport of a foreign private issuer· period May 28, 2026Document · Index
May 28, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 26, 20266-KReport of a foreign private issuer· period May 26, 2026Document · Index
May 5, 20266-KReport of a foreign private issuer· period Mar 31, 2026Document · Index
May 5, 20266-KReport of a foreign private issuer· period May 5, 2026Document · Index
Apr 14, 20266-KReport of a foreign private issuer· period Apr 14, 2026Document · Index
Mar 18, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Feb 24, 20266-KReport of a foreign private issuer· period Feb 24, 2026Document · Index
Feb 24, 2026IRANNOTICEIRANNOTICEDocument · Index
Feb 24, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Feb 24, 20266-KReport of a foreign private issuer· period Feb 24, 2026Document · Index
Jan 12, 20266-KReport of a foreign private issuer· period Jan 12, 2026Document · Index
Jan 9, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Dec 10, 20256-KReport of a foreign private issuer· period Dec 10, 2025Document · Index
Nov 17, 20256-KReport of a foreign private issuer· period Nov 17, 2025Document · Index
Nov 4, 20256-KReport of a foreign private issuer· period Sep 30, 2025Document · Index
Nov 4, 20256-KReport of a foreign private issuer· period Nov 4, 2025Document · Index
Oct 16, 2025SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Oct 1, 20256-KReport of a foreign private issuer· period Oct 1, 2025Document · Index
Sep 19, 20256-KReport of a foreign private issuer· period Sep 19, 2025Document · Index
Aug 11, 20256-KReport of a foreign private issuer· period Aug 11, 2025Document · Index
Aug 5, 20256-KReport of a foreign private issuer· period Jun 30, 2025Document · Index
Aug 5, 20256-KReport of a foreign private issuer· period Aug 5, 2025Document · Index
Jun 27, 202511-KAnnual report of employee stock plans· period Dec 31, 2024Document · Index
Jun 17, 20256-KReport of a foreign private issuer· period Jun 17, 2025Document · Index
Jun 5, 20256-KReport of a foreign private issuer· period Jun 5, 2025Document · Index
May 27, 2025SDSpecialized disclosure report (conflict minerals)Document · Index
May 23, 20256-KReport of a foreign private issuer· period May 23, 2025Document · Index
May 14, 20256-KReport of a foreign private issuer· period May 14, 2025Document · Index

Insider filing activity

0 Form 4 filings appear in Fresenius Medical Care AG’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-Misc Health & Allied Services, NEC

All 6 companies in Services-Misc Health & Allied Services, NEC

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001333141 and XBRL company facts. Fresenius Medical Care AG on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.